The Netherlands Commission on Genetic Modification (COGEM) commissions third-party research to support its work. The following project is open for enrollment: Germline modification and new gene therapies; an exploration. This project is a collaboration with the Central Committee on Research Involving Human Subjects (CCMO), and aims to gain insight into the likelihood of unintended germline modification in new (non-viral) gene therapies to support risk analysis. Interested parties are invited to submit a project bid. More information can be read here.